STAT6 and neoplasm: In line with these studies, STAT6 pharmacologic inhibitors reduced tumor growth and metastatic process in both breast and gastric cancer through modulation of macrophage M2 polarization (Binnemars-Postma et al., 2018; Lu et al., 2018).